What's new

We’re pleased to announce that the newest location in our ultraviolet (UV) radiation monitoring network is now online. Emerald is the fourth location in Queensland to join our network of real-time UV data.

In Australia, skin cancer accounts for around 80% of all newly diagnosed cancers each year and UV radiation from the sun is one of the leading causes of skin cancer. With high UV radiation year-round in many parts of Australia, people who regularly work outside face a higher risk of developing cancer from sun exposure.

Production of nuclear medicine at ANSTO’s Nuclear Medicine facility was halted on 21 June following an accident in which the hands of three workers were exposed to radiation.

ARPANSA is aware that there is a lot of concerning misinformation circulating throughout the community about the possible impacts of Australia’s planned roll-out of the 5G mobile network.

ARPANSA’s CEO, Dr Carl-Magnus Larsson has amended a licence issued to the Australian Nuclear Science and Technology Organisation (ANSTO) to operate the ANSTO Nuclear Medicine (ANM) facility.

We’re pleased to be partnering with the Central Highlands Regional Council to establish Queensland’s fourth location for collection of real time ultraviolet (UV) data.

At ARPANSA, we set the safety standard sets limits for exposure to radio frequency (RF) electromagnetic energy (EME) that is emitted by mobile phones and other wireless technologies. These limits are set well below levels at which harm to people may occur. The operating frequencies of the 5G network are included within the limits set by the ARPANSA safety standard.

The Governor-General has reappointed Dr Carl-Magnus Larsson as the CEO of ARPANSA for a term of three years.